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ABSTRACT 
 
BACKGROUND 
           Tuberculosis because of its increasing prevalence continues to be the 
major burden in our country. Inspite of the advanced studies performed in the 
field of medicine, it continues to be a major burden. Pulmonary tuberculosis is 
most common. Among the extra-pulmonary infections, lymph node 
involvement is the most common. It is the most common cause of 
lymphadenopathy in the developing countries. Various modes of treatment are 
available which includes radiation, chemotherapy and antibiotics. 
AIMS AND OBJECTIVES
 
 To study about the incidence of tuberculous cervical lymphadenopathy. 
 To study about the clinical presentations (signs, symptoms) of 
tuberculous cervical lymphadenopathy. 
 To correlate clinical diagnosis with the histopathological findings of 
tuberculous cervical lymphadenopathy and to interpret the results. 
 To study about the clinical work-up and the various management options, 
their outcome and to follow up the clinical behaviour and improvement in 
the course of tuberculous cervical lymphadenopathy for a period of not 
more than 6 months. 
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MATERIALS AND METHODS 
           The prospective study was conducted on 100 cases presenting to the 
outpatient department of GOVT.KILPAUK MEDICAL COLLEGE AND 
HOSPITAL with the signs and symptoms suggestive of tuberculous cervical 
lymphadenitis out of which 70 cases proved to be positive for tuberculous 
cervical lymphadenopathy. This study was conducted on patients presenting to 
the OPD during the period of Aug 2013 to Aug 2014. This study was conducted 
by collecting data from individual patients in the form of pretested proforma. 
All the patients were exposed to FNAC/Excision Biopsy and were started on 
Anti – tuberculous treatment only after confirming the diagnosis based on the 
clinical findings and the histopathological reports. 
RESULTS 
        In our present series, the incidence of tuberculous cervical 
lymphadenopathy was maximum in the age group of 21-30 years (35 cases-
50%). The disease showed an increasing incidence in females as compared to 
the male patients, with the female to male ratio being 1.5:1. It is more common 
in the lower socio-economic status people (90%). The disease shows increased 
incidence among the rural population which accounts for about 70% of the 
cases. All the 70 cases presented with the complaint of swelling in the neck. 14 
cases presented with fever, 7 cases each presented with pain, weight loss and 
cough respectively. About 70% of the cases presented within 3 months of the 
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start of the symptoms. The left side nodes were  most commonly involved 
(57.1%). The lymph node involvement was discrete in 77.1%  and  22.9% 
presented with matted lymph nodes according to the present study. The lymph 
nodes were firm in 70% of the cases and soft in the remaining 30%. The upper 
deep cervical nodes were involved in 60% of the cases, which was the most 
common lymph node group involved in tuberculous cervical lymphadenopathy 
in previous studies also. 
57.1% % of the cases presented with raised ESR in the present study. 8.6% of 
the cases had features suggestive of pulmonary tuberculosis on chest x-ray. 
82.9% of the cases showed caseating granuloma on FNAC. FNAC was 
inconclusive in 17.1% of the cases which were then subsequently subjected to 
Excision Biopsy which proved positive for tuberculous cervical 
lymphadenopathy. Tuberculin test was positive in 27.1% of the cases. 
      The patients were then categorised as Category I or Category II patients and 
were put on Anti-tubercular treatment based on the histopathological 
(FNAC/Excision Biopsy) reports and were followed up for a period of 6 
months. 65 cases were symptom free at the end of the study. 
INTERPRETATION AND CORRELATION 
       According to the present study, tuberculous cervical lymphadenopathy was 
more common among the female population with an increasing incidence in the 
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21-30 years of age. Swelling in the neck was the most common presenting 
complaint followed by fever, pain, weight loss and cough. Upper deep cervical 
group of nodes were the most commonly involved and most of the nodes were 
discrete and firm in consistency. All the patients were subjected to 
histopathological examination (FNAC/Excision Biopsy) and were started on 
ATT based on the reports and as per the RNTCP guidelines. All the patients had 
a 100% cure rate at the end of the study which included the follow up period of 
6 months. Surgical treatments are only adjunctive to chemotherapy and not a 
replacement. 
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INTRODUCTION 
       Tuberculosis remains to be the major health burden primarily affecting the 
lower socio-economic status people in our country. 
      In tuberculosis, the commonest type of infection is pulmonary tuberculosis. 
In extra pulmonary tuberculosis, lymph node involvement is the most common 
presentation. Cervical lymph nodes are affected frequently. Peripheral and 
mediastinal nodes are seen in immunocompromised population like HIV. 
(1) 
    The general hospitals witness a staggering 2-3% of patients suffering from 
glandular tuberculosis. It also leaves a permanent scar, often in parts of body 
that are exposed ,affecting the general confidence of the patients. The treatment 
modality for TB have changed from  time to time , ranging from royal touch to 
chemotherapy, antibiotics and surgery. 
    My study focussed on 70 patients with cervical lymph node during a period 
of one year from August 2013 to August 2014. 
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AIMS AND OBJECTIVES 
 To study about the incidence of tuberculous cervical lymphadenopathy. 
 To study about the clinical presentations (signs, symptoms) of 
tuberculous cervical lymphadenopathy. 
 To correlate clinical diagnosis with the histopathological findings of 
tuberculous cervical lymphadenopathy and to interpret the results. 
 To study about the clinical work-up and the various management options, 
their outcome and to follow up the clinical behaviour and improvement in 
the course of tuberculous cervical lymphadenopathy for a period of not 
more than 6 months. 
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REVIEW OF LITERATURE 
HISTORY 
                There are evidences showing that ancient Indians like Manu and 
Sushrutha have described  tuberculous  lymphadenopathy is a disease of  the 
unclean. 
               Hippocrates also described tuberculosis as „phthisis‟ meaning „I am 
wasting‟. (2) 
              The old name for cervical tuberculous lymphadenitis is scrofula, 
meaning „glandular swelling‟ in Latin. In French it is referred as „full necked 
sow‟ because of its resemblance with pig‟s neck. 
           In early days it was thought that the king‟s touch can cure the disease 
popularly known as „royal touch‟. There was also a saying dated back to 496 
AD by a king „I touch thee, god heals thee‟. (3) 
              The royal touch was finally abandoned after being practised for a 
period of 7 years by  the English and 13 years by the French kings and queens. 
The most popular theory put forward before 1886 was by Dole boe. He 
proposed „THEORY OF OBSTRUCTION‟, which states that it is made up of  
enlargement of numerous small glands made visible by obstruction. Large 
caseating glands are produced by the fusion of multiple small glands. 
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        Sylvius coined the term „Tubercle‟ following his serial observations in post 
mortem examinations to the typical nodular lesions. Laennec proved that 
tuberculosis can also occur in various parts of the body similarly by 2000 post 
mortem examinations. 
      The infectious nature of tuberculosis was recognized in early days, only to 
be proved experimentally by Villemin in 1865 by injecting the tubercle material 
into a rabbit. 
(2) 
 Koch discovered the causative organism of tuberculosis as 
„tubercle bacilli‟ in march 24 ,1882. 
     France became the first country to introduce the B.C.G. vaccination in 1921. 
In developed countries, better economy, health education and awareness 
reduced  the incidence of tuberculosis. 
          The advent of chemotherapy revolutionised the treatment for 
tuberculosis.
(3) 
The milestones in the development of chemotherapy 
(2)
  are., 
            1.1943- Streptomycin discovered by WALKSMAN. 
            2.1946-PAS discovered by LEHMANN.
 
            3.1952-Isoniazid discovered by JACK BERNSTEIN ET AL. 
            4.1966- the discovery of Rifampicin. 
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EMBRYOLOGY, ANATOMY AND PHYSIOLOGY OF LYMPH NODES 
In embryo, at the end of 5
th
 week the lymphatic system begins to develop. There 
are two theories describing the development of the lymphatic system. First 
theory was introduced by SABIN in 1902 which describes the lymphatic 
System development as a diverticulae of the endothelium of vein. Another  
Theory was introduced by HUNTINGTON & MCCLURE in 1909 regarding 
the sprouting of endothelium in  mesenchymal cleft which fuse and form  the 
lymphatic system.  
In embryo, at the end of 6
th
 week, local dilatations of the lymphatic channels 
form 6 primary lymph sacs                                          
1. Jugular lymph sacs are two in number which are present at the junction of 
the subclavian vein with the anterior cardinal vein. 
 
2. Iliac lymph sacs are two in number and present at the junction of the iliac 
vein with the posterior cardinal vein. 
 
3. Retroperitoneal lymph sac which is one in number present in the root of 
the mesentery on the posterior abdominal wall. 
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4. At the level of the adrenal glands and posterior to the retroperitoneal 
lymph sac
 (4)
  is situated the cistern chyli. 
Lymph vessels to the head, neck and upper limbs  develop from the  jugular 
sacs  
Lymph vessels to the lower limbs develop from the  iliac sacs . 
Lymph vessels to the gut develop from the retroperitoneal and cisternal  sacs. 
Right and left thoracic duct develop from the union of  the cisterna chyli and the 
two jugular sacs. These ducts join the venous system near the angle of 
subclavian  and internal jugular vein at base of the neck
 
Fig 1 – Embryology of the lymph node 
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Lymph node  develops  from lymph sacs which are  invaded by the 
mesenchymal cells to form the lymphatic sinuses or channels. Germinal 
lymphocyte production does not occur in the lymph node  just before or after 
birth whereas the lymphocyte present in the node before birth develops from  
the thymus. 
  LYMPH NODE 
       It has two parts: the medulla and cortex. Medulla consists of  network of  
minute lymphatic channels whereas the cortex contains lymphoid follicle and 
reticular fibres. In the medulla,  afferent lymphatics are filtered and collected in 
the hilum by efferent lymphatics. Cortex  mostly encircles the lymph node 
except in the  hilum. The lymphnodes are many in number in the  neck, axilla, 
mediastinum, mesentery, posterior  abdominal wall and the pelvis. 
    It consists of the capsule, trabeculae and the reticular tissue with the cells 
embedded within it. 
CAPSULE AND TRABECULAE 
The capsule is made up of collagen fibres, elastin fibres and few fibroblasts. It 
encircles the node completely and extends into its contents dividing it into small 
compartments. Those extensions are termed the trabeculae and they resemble in 
structure with that of the capsule and form the supporting tissue of the node. 
(6) 
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The afferent lymphatics drain into the sub capsular lymphatic plexus. The 
reticulum consists of reticular cells and fibres. 
 
 
Fig 2 – Structure of the lymph node 
 
 
RETICULAR FIBRES 
The fibres produced by the primitive reticular cells are termed reticular fibres 
which consists of fine collagen. These are many in number and form a thick 
meshwork around the cortex, blood vessels and the lymphoid follicles. 
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CELLS OF LYMPH NODES 
The lymph nodule consists mainly of the B-lymphocytes. The lymphoblasts 
occupy the paler germinal centre of the nodules which are stimulated by the 
antigens. These divide more repeatedly giving rise to many B-lymphocytes and 
they aggregate to form the dark rim around the germinal centre. They mature 
into plasma cells which are seen mainly in the medullary cords which form the 
antibodies which then ultimately reach the efferent vessel and the blood stream. 
The medullary cords consist of the T-lymphocytes which form the intervening 
tissue between the nodules. 
The reticular fibres consist of the fibroblasts which were previously termed the 
reticular cells. The lymphatic sinuses consist of numerous macrophages which 
phagocytose the antigens and ultimately present to the lymphocytes. 
(7) 
 
AFFERENT VESSELS 
The vessels enter at different parts from the periphery which after dividing form 
a dense plexus in the substance of the capsule and open into the sub capsular 
lymphatic plexus which is in continuity with the lymphatic sinuses of the 
cortex. The vessel while entering the node loses all its coverings except the 
endothelial covering. 
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EFFERENT VESSELS 
The vessels originate  from the lymphatic sinuses of the medulla and terminate 
at the hilum. The passage of the lymph though the sinus slows down gradually 
which arrests the morphological elements carried in the lymph. 
PHYSIOLOGY OF THE LYMPH NODE 
Lymph node plays an important role in the defence mechanism of the body. 
When there is an infection in the proximal part of the gland, the distal part gets 
inflamed due to the localisation of the bacteria and their toxins. They play an 
important role in the phagocytosis and destruction of the invading organisms. 
No organism or foreign body can enter the blood stream without getting filtered 
at the lymph node. 
Bacteria enter the blood stream slowly through the lymphatics but the toxins 
and the viruses of large molecular weight(>20,000 LMV) do not enter the blood 
stream if the lymphatics are blocked. Immobilisation reduces the affected area 
and aids in the resolution. It also plays an important role in the production of the 
immunoglobulins. 
(8) 
ANATOMY OF THE LYMPH NODES OF THE NECK 
There are about 800 lymph nodes all over the body out of which around 300 lie 
in the neck. Lymph nodes of the neck are particularly targeted by tuberculosis. 
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Nodes of the neck are involved in infections of oral cavity, nasal cavity, ear and 
scalp. Neck nodes account for 90% of chronic lymphadenitis of the body. 
(9) 
CLASSIFICATION OF LYMPH NODES OF NECK 
 Circular group of nodes 
 Vertical group of deep cervical nodes. 
CIRCULAR CHAIN OF NODES: 
It is composed of 
A) OCCIPITAL NODES: 
These are one or two nodes located between mastoid process and external 
occipital protuberance. They are enlarged in infection of back of the scalp. 
B) POST-AURICULAR NODES: 
Present over the mastoid process behind the pinna. They are involved in 
infections of temporal region of scalp, back of the pinna and external auditory 
meatus.  
C) PRE-AURICULAR NODES: 
Located exactly in front of tragus, superficial to parotid fascia. Outer surface of 
the pinna and side of the scalp drains into pre-auricular nodes. 
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D) PAROTID NODES: 
They are located both in the substance of the parotid and deep to it., between it 
and lateral wall of pharynx.  
The deeper nodes drain  
                                       1.nasopharynx  
                                       2.back of the nose. 
Superficial group drain  
                                       1.eye lids. 
                                       2.front of the scalp. 
                                       3.external auditory meatus. 
                                       4.tympanic cavity.. 
E) FACIAL NODES: 
Composed of deep and superficial nodes. 
Superficial group consists of  
a) Infra-orbital :located just below orbit. 
b) Buccinator: over the buccinator muscle , lateral to the angle of the 
mouth. 
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c) Supra-mandibular: over the mandible, in front of the masseter 
around the facial artery.                  
They drain the conjunctiva, eye lids, nose and cheek. 
DEEP GROUP: 
They are situated around the maxillary vessels and in correspondence to the 
external pterygoid muscle. They are involved in infections of  a) temporal fossa 
b)infra-temporal fossa c) back of the nose d) pharynx. 
F) SUB-MANDIBULAR NODES: 
These are located in relation to the sub-mandibular salivary gland in the sub-
mandibular triangle. The lymph nodes are directly in contact with salivary gland 
situated under the deep fascia. 
They drain  
a) Side of the nose. 
b) Inner angle of eye. 
c) The cheek. 
d) Angle of mouth. 
e) Upper lip 
f) Outer aspect of lower lip. 
g) Gums 
h) Side of the tongue. 
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G) SUB-MENTAL NODES: 
                                           Situated in the sub-mental triangle. They are 
involved  in infections of central part of lower lip and floor of the mouth. They 
also drain the apex of the tongue.. 
H) SUPERFICIAL CERVICAL NODES: 
                                           Situated on the outer border of sternomastoid around 
the external jugular vein. They are involved in infections of the parotid gland 
and lower ear. 
I) ANTERIOR CERVICAL NODES: 
                                         Located in the midline of neck, in front of trachea and 
larynx. Consists of deep and superficial group of nodes. 
Superficial group: they are located around the anterior jugular vein and receive 
lymph from skin of the neck. They are insignificant. 
1) Deep group:  
 
a) Infra-hyoid nodes: present over the thyrohyoid membrane 
and receive lymph from front of the larynx 
b) Pre-laryngeal nodes:  located over the cricothyroid ligament.  
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They drain larynx. The afferent vessels pass through the 
foramen in the middle of cricothyroid ligament. They also 
assist in receiving lymph from the thyroid.  
c) Pre-tracheal nodes: they are located in correspondence to the 
inferior thyroid veins in front of the trachea and receive 
lymph from the thyroid and trachea. 
 
EFFERENT  VESSELS OF  CIRCULAR CHAIN: 
The efferent vessels directly receive lymph from the nodes mentioned above to 
the deep cervical nodes except from facial and submental nodes. The efferents 
pass from facial and submental nodes pass to submandibular nodes first. 
 
VERTICAL GROUP OF DEEP CERVICAL NODES: 
        These are situated in relationship to carotid sheath. A small group of nodes 
are located behind the pharynx and they are called retropharyngeal nodes. They 
receive lymph from pharynx, auditory tube and back of nose.  
        The vertical group of nodes lie along the pharynx, trachea and 
oesophagus,from the base of the skull to the root of the neck. They are divided 
conventionally into superior deep cervical and inferior deep cervical by 
omohyoid. Some of the nodes  project beyond the posterior margin of 
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sternomastoid into posterior triangle of neck. A small number of nodes are 
situated in the groove between trachea and oesophagus along recurrent 
laryngeal nerve. They are known as paratracheal nodes and they drain the 
thyroid. 
Two of the deep cervical nodes are specified: 
1.Jugulo-digastric nodes: the node for tonsil. 
2.Jugulo-omohyoid node: a node located on the common carotid above the point 
just above where the anterior belly of omohyoid crosses the vessel. It plays a 
vital role in the drainage of tongue.
(10) 
 
EFFERENTS OF VERTICAL CHAIN: 
The lymph from the deep cervical trunk enters one trunk –jugular lymph trunk, 
that leaves the inferior deep cervical nodes. On the right side it enters the 
junction of subclavian vein and internal jugular vein. On the left side , it joins 
the thoracic duct.  
 
AFFERENTS OF THE VERTICAL CHAIN: 
The deep cervical nodes drain the entire head and neck, directly or indirectly 
from the circular chain. 
(10) 
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Fig 3 – Anatomy of the lymph nodes draining the head and neck 
 
 
 
Fig 4 – Anatomy of the lymph nodes of the head and neck 
 
34 
 
                                      BACTERIOLOGY 
 
A)      TUBURCLE BACILLI 
 
1. Human  mycobacterium  tuberculosis 
 
2. Bovine  mycobacterium bovis 
 
3. Murine  mycobacterium microti 
 
4. Avian –mycobacterium  avium 
 
5. Cold blooded – mycobacterium  marinum 
 
B)     LEPRA  BACILLI 
 
1. Human  mycobacterium leprae 
 
2. Rat –mycobacterium lepral murium 
 
 
C)      MYCOBACTEERIA CAUSING SKIN ULCERS 
                1.   Mycobacterium  ulcerans 
2.   Mycobacterium  balnei 
     D)      ATYPICAL MYCOBACTERIA 
               1. Photo chromogens 
               2. Scoto chromogens 
               3. Non Photo chromogens 
               4. Rapid growers 
     E)      JOHNE’S BACILLUS 
               1. Mycobacterium paratuberculosis 
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     F)      SAPROPHYTIC MYCOBACTERIA 
               1. Mycobacterium butyricum 
               2. Mycobacterium phlei 
               3. Mycobacterium stercoris 
               4. Mycobacterium smegmatis 
               5. Others 
               The term „mycobacteria‟ means fungus like bacteria which are nothing 
but the slender rods showing branching filaments which resemble with that of 
the fungus mycelium. Mycobacteria are aerobic, non motile, non capsulated, 
non sporing. They are called the „Acid Fast Bacilli‟ because they do not stain 
immediately but once stained, resist decolourisation with dilute mineral acids. 
Growth is slow. The genus includes obligate parasites, opportunistic pathogens 
and saprophytes. 
Robert Koch announced his greatest discovery, the causative organism of 
tuberculosis, to the Physiological society in Berlin on 24
th
 March 1882. 
Tuberculosis in human beings is caused by either the human type or the bovine 
type of bacillus. Subsequently the other types were also described. The 
generation time of the bacilli in vitro is 14-15 hours. Colonies are formed in 
2weeks but can be delayed upto 6-8weeks. The growth is very slow and does 
not occur below 25°c or above 40º. Optimum temperature is 37ºC. Optimum pH 
is 6.4-7.0. Mycobacterium bovis is usually microaerophilic when it is primarily 
isolated but becomes aerobic on subculture. Mycobacterium bovis grows 
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sparsely whereas Mycobacterium tuberculosis grows luxuriantly but the growth 
can be stimulated by 5-10%CO2 or by adding glycerol but does not grow in 
media containing 500mg of  p-nitrobenzoic acid. But the addition of these 
growth stimulants has either no effect or inhibits the bovine strains. 
Koch grew the tubercle bacilli on heat coagulated bovine serum. Tubercle 
bacilli are highly susceptible to fatty acids in culture media but is neutralised by 
serum, charcoal or albumin. Solid media contains egg(Lowenstein Jensen, 
Petragini or Dorset ), blood(Tarshis medium), serum(Loeffler‟s serum slope) or 
potato(Pawlowsky). Most widely used solid media is the Lowenstein medium 
without starch. This was recommended by IUAT. Lowenstein Jensen medium 
consists of mineral salt solution, coagulated hen‟s egg, asparaginase and 
malachite green. Malachite green is a selective agent inhibiting other bacteria. 
Another cheap alternative to the LJ medium is the media composed of eggs, 
coconut water and malachite green. Mycobacterium tuberculosis on solid 
medium produces dry, rough, raised, irregular colonies with a wrinkled surface 
which are tenacious, not easily emulsified, creamy white initially which 
subsequently changes to yellow/ buff colour. Mycobacterium bovis on solid 
medium forms flat, smooth, moist, white colonies which breaks up readily on 
touching. Liquid medium includes the Dubo‟s, Middlebrook‟s, Proskauer, 
Beck‟s, Sulo‟s and Sauton‟s media. Liquid media aids in sensitivity testing, 
chemical analysis, preparation of antigens and vaccines. In Dubo‟s medium, 
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there is a diffuse growth of the bacilli and contains Tween 80 (Sorbitan mono 
oleate). 
The growth of the bacilli begins at the bottom, creeps up by the sides and forms 
a pellicle on the surface which may extend along the sides above the medium in 
liquid medium without dispersing agents. Cord factor which is present in both 
the pathogenic and some non-pathogenic species is not fully responsible for the 
virulence. 
In liquid media, virulent strains tend to form long serpentine cords while the 
avirulent strains tend to grow in some dispersed fashion. Morphology of the 
colonies can be modified by the presence of bacteriophage in the strain. 
 
Fig 5 – Mycobacterium tuberculosis colonies 
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RESISTANCE: 
Mycobacterial survival depends on the material in which the bacteria are 
present. The bacilli are killed at 60°C in 15-20mins but the bacilli in the sputum 
remains alive for 20-30hours and that present in the droplet remains viable for 
8-10days. Cultures are killed by direct sunlight exposure for 2hours but remain 
viable for 6-8months at room temperature and 2years in the deep freeze cabinet 
at -20ºC. 
Mycobacteria survives on exposure to 5%phenol, 15% sulphuric acid, 3% nitric 
acid, 5% oxalic acid and 4% sodium hydroxide but destroyed by the contact of 
the culture with tincture of iodine for 5minutes, and that of 80% ethanol in 2-
10minutes. Hence, 80% ethanol is used as a skin disinfectant and a disinfectant 
for rubber gloves, clinical thermometer. Mycobacteria are sensitive to 
formaldehyde and glutaraldehyde. 
BIOCHEMICAL REACTIONS: 
Mycobacterial species can be identified by biochemical tests which includes :  
1. NIACIN TEST: 
Addition of 10%cyanogen bromide and 4% aniline in 96% ethanol to a 
suspension of culture containing human tubercle bacilli shows a canary 
yellow colour (positive reaction) while the bovine type produces a 
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negative reaction. Tubercle bacilli produce niacin when grown on a 
medium containing egg. 
 
2. ARYL SULPHATASE TEST: 
The atypical mycobacteria are grown in culture containing 0.001M tripotassium 
phosphathalein disulfate and forms aryl sulphatase. If sodium hydroxide is 
added to the medium drop by drop, a pink colour is produced which indicates a 
positive reaction. 
3. NEUTRAL RED TEST: 
Virulent strain binds neutral red in alkaline buffer solution while the avirulent 
strains do not. 
4. CATALASE-PEROXIDASE TEST: 
Aids in knowing the sensitivity of the strain to INH (Isotonic Acid 
Hydrazine).Helps in distinguishing the tubercle bacilli which are weakly 
catalase positive and peroxidise positive from atypical mycobacteria which are 
strongly catalase positive. Tubercle bacilli resistant to INH lose their catalase 
and peroxidise activity. 
To 5ml of the test culture, equal volume of 30 vol of H2O2 and 0.2% catechol 
in distilled water is added and allowed to settle for a few minutes. Catalase 
40 
 
production in indicated by effervescence and peroxidise activity by browning of 
the colonies. 
5. AMIDASE TEST: 
5 amides namely the acetamide, benzamide, carbamide, nicosanamide and 
pyracinamide are used which differentiates mycobacteria based on the ability to 
split amides. The bacilli in the solution is incubated with 0.00165M  solution of 
the amide at 37°C and 0.1ml of MnSo4, 4H20, 1.0ml of phenol solution and 
0.5ml of hypochlorite solution are added  and placed in boiling water for 
20minutes. A positive test is indicated by the presence of blue colour.                                   
6. NITRATE REDUCTION TEST: 
This is positive with Mycobacterium tuberculosis only. 
(11) 
 
ANTIGENIC PROPERTIES: 
Specificity of the group is due to polysaccharide  and type specificity is due to 
the protein antigens. Delayed hypersensitivity is developed to the protein of the 
bacillus(tuberculin) following infection by the tubercle bacilli. 
Tuberculin from Mycobacterium tuberculosis, Mycobacterium bovis and 
Mycobacterium microti appears to be indistinguishable. There is some antigenic 
relationship between the protein antigens of tubercle bacilli and atypical 
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mycobacteria shown by weak cross reactions in skin testing. A 
ribonucleoprotein from Mycobacterium tuberculosis reacts with serum from 
patients with lepromatous leprosy. 
Mycobacterium tuberculosis has shown to be antigenically homogenous to 
Mycobacterium bovis and Mycobacterium microti by agglutination, agglutinin 
absorption, gel precipitation and passive hemagglutination. 
BACTERIOPHAGE: 
4 phage types of tubercle bacillus: 
A-Commonest type worldwide 
B-Occurs in Europe and North America 
C-Seen rarely 
D-Common in India and neighbouring countries. 
(11) 
Phage 33D from a lysogenic environmental mycobacterium lyses all the types 
of Mycobacterium tuberculosis but not BCG. 
MOLECULAR TYPING: 
Tubercle bacilli are genetically homogenous where certain strains contain a 
chromosomal insertion sequence IS6110 which acts as a transposon. DNA  
fingerprinting of these insertion sequences are employed for the diagnosis of the 
infection, epidemiological studies for tracing the source of outbreaks. 
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HOST RANGE: 
Natural infection in human beings, other primates, dogs and other animals who 
have close contact with human beings is caused by Mycobacterium tuberculosis 
which is highly infectious for guinea pigs and hamsters but non-pathogenic for 
rabbits, cats, goats, bovines and fowls. Mice are moderately susceptible and 
develop progressive infection following intra peritoneal, intravenous or 
intracerebral inoculation. 
Mycobacterium bovis produces tuberculosis in cattles, human beings, primate 
carnivores which includes dogs, cats and badgers, swine and parrots. BCG, the 
tuberculin vaccine is the attenuated strain of Mycobacterium bovis. It is highly 
pathogenic for rabbits, guinea pigs and calves, moderately pathogenic for dogs, 
cats, horses and rats and non-pathogenic for fowls. 
Mammalian tubercle bacilli are considered as variants of single species of 
Mycobacterium tuberculosis. Heterogenous group of tubercle bacilli isolated in 
Africa which shows properties intermediate between the human and bovine 
types are termed the African type. Human type of bacilli isolated in South India 
which has low virulence for guinea pigs are termed the Asian type. 
Mycobacterium avium causes tuberculosis in birds, „Yersin type ‟ tuberculosis 
in rabbits and mice-proliferating without producing macroscopic tubercles. It is 
non-pathogenic for guinea pigs and rats. 
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Mycobacteria microti causes focal lesions in human beings, guinea pigs, rabbits 
and calves.
(11)
  It causes tuberculosis in voles. 
MORPHOLOGY: 
Tubercle bacilli vary in length from 0.8-5.5µ and width from 0.2-0.6µ.They 
were examined under electron microscopy by Rosenblatt et al in 1942. Tubercle 
bacilli are rod shaped with rounded/ slightly flattened ends. Other forms 
includes curved, bean shaped and oval forms. 
Human form is long, slender whereas the bovine form is short and stumpy. 
 Avian type is pleomorphic. 
STAINING PROPERTY: 
Tubercle bacilli are termed the acid fast bacilli due to the presence of lipoid 
fraction containing free hydroxyl groups known as mycolic acid. These are 
present in the capsule of the organisms (discovered by Anderson in 1938 ). 
Ziehl Neelson developed a staining technique with 5% carbol fuchsin in 
catechol for a few minutes at a higher temperature or for longer time at a lower 
temperature following which they resist decolourisation with potent 
hydrochloric acid. 
(12) 
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Fig 6 – Ziehl – Neelson staining 
FLUOROSCEIN TECHNIQUE OF DETECTING BACILLI: 
 Tubercle bacilli absorb acromine fluorescent dye. When culture containing 
tubercle bacilli is exposed to UV light , the bacilli is seen as brilliantly 
illuminated structures against dark background even under the low power 
microscope. 
CHEMISTRY OF THE BACILLI: 
(12) 
Bacilli contain the following constituents: 
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PROTEINS: 
Upon injection, protein bound to a wax fraction induces tuberculin sensitivity. 
Partially purified tuberculin contain a mixture of small proteins (10kDa). 
CARBOHYDRATES: 
Contains polysaccharide whose role in pathogenesis is uncertain. 
LIPOID FRACTION: 
Includes mycolipids (long chain fatty acids)
(13)
,  waxes and phospholipids. 
Muramyl dipeptides with mycolic acids cause granuloma formation. Isolated by 
Anderson in 1937. 
 Responsible for resistance to chemical 
 Adjuvant effect (waxD) enhancement of antigenic immunogenicity 
 Intracellular persistence in non-activated macrophages by means of 
inhibition of the phagosome lysosome formation 
 Complement resistance 
 Virulence is due to the cord factor (trehalose 6,6-dimycolate) (14) 
SOURCE OF INFECTION: 
TONSILS: 
In many cases, the tubercle bacilli enters through the tonsils of the 
corresponding side so that the lesions are either minimal/ has healed which 
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makes its identification impossible. Upper deep cervical group of lymph nodes 
are most commonly involved. The tuberculous process is usually restricted to 
the clinically affected group of lymph nodes in more than 80% of the patients 
but a primary focus in the lungs should always be suspected.
(9)
  On examination, 
tonsils are not useful to aid in the presence or absence of infection due to 
chronic tonsillitis. 
(15) 
TOOTH: 
This portal of entry should be suspected only when the submandibular or 
submental group of lymph nodes are primarily involved. 
(16)
 If the portal of 
entry is the scalp, then the posterior triangle nodes are mainly involved which 
receives the lymphatic vessels from the adenoid also. 
PATH OF INFECTION: 
Main source of infection are patients who are open case of tuberculosis or 
carriers. 
Contamination of the breast milk is extremely rare even when the mother is a 
tuberculous patient. Contamination of the cow milk is possible but because of 
the improvement in hygienic measures and the use of pasteurised milk, 
contamination of the cow milk is almost eradicated. 
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PORTAL OF ENTRY: 
(2) 
The bacilli are carried by air borne infections which gets filtered at the nostrils 
and adenoids to produce lesions at the site of the draining lymph nodes. 
DROPLET INFECTIONS: 
 
TB carriers or patients possess thousands of bacilli in throat and nasal passages  
which spread during the process of coughing/ sneezing. Bacilli enters the host  
without losing much vitality even though some bacilli cling to the dust, clothes,  
screens, utensils for several weeks and start losing their vitality. 
 
DUST INFECTION: 
 
TB bacilli in the sputum when spit on open streets gets dried and can remain  
alive for several months which can enter the human body while inhaling but is  
secondary to droplet infection. 
 
INTRA-UTERINE INFECTIONS: 
Previous theories showed that the infection is usually postnatal and placenta is  
not a carrier of infection but  recent theories have shown that the foetus can get  
infected even upto the extent of septicaemia without positive tuberculin test. 
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RETROGRADE LYMPHATIC SPREAD: 
 
Lymphatic spread is common in tuberculous adenitis. The involvement of the  
lower deep cervical group of lymph nodes raises suspicion that it is involved  
secondary to mediastinal group of nodes. 
Hematogenous spread is a rare phenomenon. Hematogenous involvement  
occurs in 50% instances of primary complex in younger age group and is  
associated with multiple lymph node involvement before the tuberculin test  
becomes positive. It is commonly associated with miliary tuberculosis or  
tuberculous meningitis. 
In progressive pulmonary tuberculosis, extra- pulmonary tuberculosis is  
uncommon.   
 
EPIDEMIOLOGY OF THE DISEASE: 
 
TB, in the global prevalence, has been the most important of all the human  
Infections, with massive morbidity and mortality. Evidence of spinal  
tuberculosis has been identified in the Egyptian mummies. Prevalence increased 
 rapidly following urbanisation and overcrowding, but now the incidence has  
come down with the improvement in standards of living. TB has been rightly  
described as the “parameter of social welfare”.  
 
About 20 million open cases of tuberculosis are reported at any point of time all 
 over the world, out of which 70-80% belong to the poorly developed nations. 
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About 4-5million new cases of open pulmonary tuberculosis arise each year out  
of which 3million people die each year because of TB. 
(17) 
TB is the highest burden in India where 1.8million persons develop TB out of  
which 0.8million are smear positive. India accounts for 1/5
th
 of the global  
burden of TB. In India, 2 out of every 5 are infected with TB bacilli and 2 
 persons die of TB every 3minutes. 0.4million die of TB every year. 
(18) 
In developing countries, prevalence of both infection and active disease is high  
and mortality is increased in infants and children less than 5years of age. The  
infective rate is high by the age of 20 with a rate of 10-15%. 
(19) 
Predisposing factors which favours the development of tuberculosis includes  
malnutrition, low socio-economic status, occupational exposure to silica,  
medical and paramedical workers who are in direct contact with the patients and 
 infectious materials, population from  the hilly regions who settle down in the  
plains. 
 
Infections like measles, typhoid, sore throat and acute respiratory tract ailments  
may break down the host resistance and precipitate tuberculosis. Worldwide, the   
most important risk factor for the development of tuberculosis is HIV induced  
immunodeficiency. HIV and TB form a deadly combination. TB accounts for  
25% of the deaths among people with HIV. 
(20) 
 
In Western countries, because of the improvement in standards of living,  
attention to diet, housing, sanitation, preventive interventions and specific anti- 
tubercular drugs, the incidence of cervical lymphadenitis is so negligible which  
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is a successful attempt in eradicating tuberculosis. But in India, the problem still  
remains unresolved due to poverty, uncooperative patients, infections and  
irregular treatments. 
 
ATYPICAL MYCOBACTERIA: 
 
This group includes those bacilli other than the human or bovine tubercle bacilli  
which can also cause the human disease clinically resembling  that of  
tuberculosis and  has been termed the „atypical‟, „anonymous‟ or  „unclassified‟  
mycobacteria.
(21)
  „Environmental or opportunistic mycobacteria‟ is the  best    
suited  term  for  these  bacilli as their natural habitat  is either soil or water 
 and  cause  opportunistic infection  in   human beings. Over  recent years, 
 the  term  „non- tuberculous mycobacteria ‟ has  gained  worldwide   
acceptance.  They are also termed the „paratubercle‟, „tuberculoid‟ and  
 MOTT  (mycobacteria   other  than  tubercle )  bacilli. There is no proof of  
evidence of direct human to human transmission.  
Saprophytic mycobacteria such as M.smegamtis and M.phlei are not capable of  
infecting human beings or animals.
(21) 
At times the human infection with them is  
common while the disease is rare because, when injected into the guinea pigs,  
they do not cause progressive disease. 
 
In developed countries, where tuberculosis is almost eradicated or under 
 control, atypical mycobacteria is gaining importance. Some may produce  
pulmonary disease which becomes almost indistinguishable from tuberculosis  
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while others may cause lymphadenitis. In Western countries, the spread of HIV  
has increased the disease caused due to atypical mycobacteria. 
(22) 
 
Atypical mycobacteria are almost resistant to the anti- tubercular drugs like 
 Streptomycin and Isoniazid and sensitive to Rifampicin. Usually a combination 
 of drugs is used but chemotherapy does not help in such cases and surgery  
becomes mandatory. 
 
CLASSIFICATION: 
RUNYON’S CLASSIFICATION OF ATYPICAL MYCOBACTERIA  
 on the basis of  pigment production and the growth rate).  
Identification of the species is by other classifications. 
Group I   – Photo chromogens 
Group II  – Scoto chromogens 
Group III – Non photo chromogens 
Group IV – Rapid growers 
 
GROUP I – PHOTO CHROMOGENS: 
They are slow growing but the growth is faster than that of the tubercle bacilli.  
They form colonies which produces no pigment in the dark but when exposed to  
light for 1hour and after reincubation, a yellow orange pigment appears.   
Mycobacterium kansasi causing pulmonary disease which resembles that of  
tuberculosis. 
Mycobacterium marinum causing swimming pool granuloma. 
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Mycobacterium simiae and Mycobacterium asiaticum causing pulmonary  
disease.
(23) 
GROUP II SCOTOCHROMOGENS: 
Do not cause human disease except for Mycobacterium scrofulaceum. Strains 
 produce yellow-orange-red pigmented colonies even in the dark. 
M.scrofulaceum which causes cervical adenitis in children. 
(24) 
M.gordonae which rarely produces human infection. 
M.szulgai also belongs to this group. 
GROUP III NON-PHOTO CHROMOGENS: 
Colonies resembling that of tubercule bacilli do not form pigment even on  
exposure to light. 
(25) 
M.intracellulare was first discovered as a human pathogen at the Battey State 
 Hospital for TB in Georgia, USA. Hence, it is also known as the „Battey 
 Bacilli‟. This produces the pulmonary and renal infection and  
lymphadenopathy. 
 M.avium  rarely causes cervical adenitis in children and  
lung disease in the elderly. 
M.xenopii  occasionally causes chronic lung disease in human beings. 
There are many controversies about whether M.avium and M.intracellulare  
should be considered as a variant of single species or are separate species and is  
still a debate. 
(26)
 As of now, they are considered in complex along with  
M.scrofulaceum and the entire complex is called the M.avium-intracellulare-
scrofulaceum / MAIS complex. 
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GROUP IV RAPID GROWERS: 
This group produces colonies within 7days of incubation at 37°C or 25°C. 
The chromogenic rapid growers are saprophytes (e.g.: M.smegamtis, M.phlei). 
M.fortuitum and M.chelonei which causes chronic abscess and do form any  
pigment. 
M.fortuitum produces pulmonary lesions which is indistinguishable  
radiologically from typical tuberculosis. 
 
SKIN  PATHOGENS: 
Skin lesions occur either as localised/ generalised in leprosy or tuberculosis. 
 Mycobacteria which causes skin pathogens are M.ulcerans and M.marinum.  
They produce granulomatous lesion and chronic ulcers on the skin. 
(27) 
These  
mycobacteria multiply optimally at skin temperature and systemic invasion/ 
 lymph node invasion does not occur. 
 
PATHOGENESIS AND PATHOLOGY: 
PATHOGENESIS: 
Five factors aids in understanding the pathogenesis of tuberculosis which 
 includes: 
Virulence of the mycobacteria which is not related to any endotoxin. 
Relationship of the hypersensitivity to the immunity against the infection 
Pathogenesis of caseation necrosis 
This ability of Mycobacterium tuberculosis to induce the disease in  
experimental animals is due to mycoside in the lipoid fraction of the bacterium. 
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 Mycosides are covalently linked complex lipids and carbohydrates. Cord factor  
is responsible for the serpentine, cord like growth of the Mycobacterium  
tuberculosis in vitro and is toxic to mice.  The cell wall of the bacilli contains  
wax D (a glycolipid), and muramyl dipeptide and they are powerful adjuvants 
 and is important in the development of
(28)
 delayed hypersensitivity, skin  
reactions and granulomatous inflammation at the sites of the infection. 
In a previous unexposed immunocompetent individual, the pathogenesis of 
 tuberculosis is based on the development of the cell mediated immunity that 
 confers resistance to the organism and results in the development of tissue  
hypersensitivity to the tuberculous antigens. Within 2-3weeks,a positive skin  
reaction that is granulomatous occurs and the centre of the granulomas become  
caseous forming typical soft tubercles. 
Sequence of events from inhalation of the Mycobacteria to the development of 
 primary foci are: 
Virulent strains enter the macrophage endosome and proliferate impairing the  
phagolysosome formation. Antigens from the bacilli reach the draining lymph 
 nodes and is presented to the CD4+T cells which are sensitised and again  
recirculate back to the site of infection where they release cytokines (IFN ɣ ) 
and  
activate the macrophages forming granulomas which trap the residual micro- 
organisms. These granulomas get caseated at the 
(29)
centre (soft tubercles), but 
 many a times there is no caseation (hard tubercles).  The granulomas are  
composed of epitheloid secretory cells and is responsible for necrosis.  
Hypersensitivity is described by the caseating response to the tubercle bacillus,  
the acquisition of the immunity and the resistance to the organism. The  
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sensitised host produces a defensive reaction and produces enhanced necrosis.  
The protective or destructive response is determined based on the fact of  
whether the primary focus of infection is localised/ generalised. 
TISSUE REACTIONS IN TUBERCULOSIS: 
Tissue response is based on the dose, virulence and viability of the bacilli and 
 whether the infection is primary or secondary (reinfection). 
PRIMARY COMPLEX: 
Bacilli usually gets lodged in the upper part of the lower lobe or the lower part 
 of the upper lobe. These undergo consolidation (Ghon‟s focus) and this  
combined with the nodal involvement is termed the Ghon complex. In primary  
infection, the lesion heals with resorption whereas in reinfection, the lesion is  
progressive and reaction is accentuated due to the development of  
hypersensitivity to the tubercle protein and localised in the area of lesion. 
This lesion in glandular tuberculosis is due to primary infection in the lungs/  
abdomen or the tonsils and the complementary lesion is in the lymph nodes. 
TUBERCLE FORMATION: 
In the initial 24 hours, leucocytes migrate to the area of infection to form a 
 centre of small abscess. The local reticulo endothelial cells / monocytes of the  
blood produces mononuclear cells which migrate and covers the bacilli. In the 
 subsequent 15-20 days, nodules/tubercles are produced by groups of epitheloid 
 cells which produce the Langhan‟s giant cells encircled by the lymphocytes. 
Tubercles consists of central area of necrosis and is surrounded by epitheloid  
cells, giant cells and in the periphery by lymphocytes with surrounding  
fibroblastic proliferation. 
(30) 
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If the resistance of the individual is good, infection may resolve without any 
 residual lesion. And  the individual develops a positive reaction to tuberculin  
in  4-6weeks following infection. 
The susceptible individuals who are not on chemotherapy develop the following 
 changes: 
CASEATION: 
 
Fig 7 – Caseating granuloma 
Due to the allergic hypersensitivity development following  infection, the most  
important pathognomic factor of tuberculous degeneration and coagulative  
necrosis of cells with coagglutination of the tissues related to fibrin and hyaline  
fibrinoid substances is caseation. This has been ascribed to the glass like 
appearance and is  therefore called the degenerated „vitreous‟. 
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LIQUEFACTION: 
Caseous focus which has arrested  growth of the bacilli is less dangerous 
 compared to progressive lesion but once  caseation occurs the healing is  
disrupted. The proliferation of the bacilli, migration of the leucocytes and  
monocytes cause the softening of caseous material forming a cold abscess 
 which may either get absorbed or burst forming a sinus. 
(31) 
 
FIBROUS CALCIFICATION AND OSSIFICATION: 
The epitheloid cells and fibroblasts are involved in the formation of precollagen 
 reticulin fibres and collagen and elastic fibres which aid in the conversion of  
the caseous focus to collagen and subsequently into the hyaline scar. 
Calcification occurs most commonly in the primary lesion. The combination  
of Streptomycin, which hastens the fibroblastic activity and INH, which  
enhances the revascularisation in caseous area thereby helping in the regression 
 of the swelling and healing of the fibrosis, should be used. Streptomycin alone  
should not be used. 
 
CLASSIFICATION OF THE TUBERCULOUS NODE BASED ON THE 
 PATHOLOGY: 
1. PROLIFERATIVE: 
Nodes are enlarged and hard. Capsule is intact. 
No periadenitis and the lymph nodes are discrete. 
2. FIBROUS: 
Lymph nodes are enlarged, hard, mobile and shows calcification on x-ray. 
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3. CASEATION: 
Caused by either  blood or lymph borne infections. Nodes are matted. Cut  
surface shows pale yellow cream caseating areas. The lymph nodes are usually  
situated deep to the deep fascia of the neck and grows on to the skin forming a  
track which ultimately leads to cold abscess. The healing of the sinus is  
indicated with puckered scar. 
(31)
 The healing of one sinus subsequently leads to 
 the  formation of the other sinus such that multiple sinuses opens on the neck.  
The scrofulodermic scar are prone for keloid formation. 
 
CLINICAL FEATURES 
Tuberculous lymphadenitis is more  common  in   females  compared   to   
males .  Most   commonly  involves   anterior  triangle   of   neck .In  the  
anterior   triangle  ,  upper  deep cervical   group   is  most   common  .  It 
occurs  in   2
nd 
decacade  of  life  . In  most   of  the  patients  onset  is  
insidious  .  It  takes  chronic   course  ,  it  starts   as a   localized  
infection .  complication   occurs   when   secondary  infection  takes   
place  . In  80%  of   the  cases  the   disease  is limited   to   the   lymph 
node  group   that    is  affected  . In   some   cases  there   may   be  a   
primary   lung   pathology  and   it  has  to  be  investigated  . 
Most  common   symptoms   are  evening  rise   of   temperature  , malaise   
and  appetite  loss.  Duration  may   vary   from    months  to  years. 
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 On  examination , the  consistency   of  lymph  node  may  be  hard   or   
fluctuant  .Inflammatory  changes  are  minimal  compared   to   other  
bacterial   lymphadenitis  . The   swelling  is non   tender  and  freely 
mobile.  skin  changes  are  minimal  . 
 The  most  common  group   affected  is  cervical(63%) ,  next  group  that   is   
involved  is  mediastinal(27%)   and  then  axillary(8%).  Mostly  it  is  
unilateral   and  it   involves  deep cervical    group  of   lymph   nodes. 
  Multiple  group  of  lymph   nodes    is  involved    if  the  origin  is  through  
hematogeneus route.  There     may  be  splenomegaly  .Toxic  symptoms  are  
present   
There  are   four  clinical  types: 
ACUTE TYPE:  common  in  infants  and   children ,  resembles  acute   
Lymphadenitis 
(32) 
CASEATING TYPE :  common  in young  adults ,neighbouring  lymph  nodes  
are also   involved  . Typical  matted  nodes  with   caseation  . cold  abscess  
and  sinuses  are  common . 
HYPERPLASTIC TYPE:  lymphoid  hyperplasia  is predominant.  Mostly  
 single  group  of    lymph node  is   involved ,  usually  it  is  firm  and  discrete 
. 
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ATROPHIC TYPE:  common  in  elderly  where  there  is  natural   
 involution.  The  nodes  are  usually   small . 
 
COURSE OF THE DISEASE: 
There  are  5  pathological  stages  (Jones  and  Campbell) . Patient   may 
present  with   any  of  these  stages  .  
(33) 
STAGE 1 :  
Lymph  nodes  are  enlarged  . They  are  firm ,  discrete  and  freely  mobile. 
There is  solid  inflammation   and  non  specific  hyperplasia. 
STAGE 2: 
Lymph  nodes  are  rubbery and  enlarged  .They  are  matted  together due  to  
periadenitis  . 
STAGE 3: 
Lymph  nodes  break down  and  liquefy  to  form  abscess  due  to  caseation. 
Pus  collects  beneath  the  fascia.   There  may  be  varying  consistency  . May 
be  fluctuant  without  inflammatory  skin  changes (cold  abscess). 
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STAGE 4: 
The deep  cervical  fascia  may  get  eroded   and  the  pus  may   get collected  
beneath  the  superficial  fascia  which  is  laborious to  form  collar  stud  
abscess  . 
 
STAGE 5: 
The  superficial  abscess  enlarges   and   then  eventually   burst  through  
the  skin when  it  gets  ulcerated resulting  in  continuously  discharging  
sinus  until  the  necrotic  material  beneath  the  deep  cervical fascia  
gets cleared . Healing  may  occur  only  when the  conditions  favour. 
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Fig 8 – Stages of tuberculous cervical lymphadenitis 
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Fig 9 – Gross picture of a tuberculous lymph node 
OTHER PRESENTATIONS 
 In 10%  individuals  there  may  be   long  stem  for  the  collar  
stud abscesses.   The  feeding  infected   node   may  be  located  in  
the  other  triangle  of  the  neck  with  abscess  presenting  in  
some  other  triangle .In   such  cases  it is necessary  to  palpate  
the  full  length  of  the   stem. 
 In  some other  cases  the  abscess   is  situated  over  the   affected  
node  and   only  small group   of  nodes  are   involved. 
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LABORATORY INVESTIGATIONS 
 RBC count 
 Hb% - may  be  microcytic  hypochromic  anemia  
 Differential count – lymphocytosis (34) 
 WBC count -  not  altered 
 ESR- raised  .  It is a prognostic  factor 
 Mantoux test – positive test has no diagnostic  value 
Negative test excludes tuberculosis 
PROCEDURE: 
0.1 ml  of   PPD  (purified  protein  derivative ) is injected in the  volar 
aspect of  the  forearm   .(0.1ml =5Tu)  After  48  to  72  hours  look  for  
induration  at  the  injected  site.  Induration  is   measured  transversely  
and  the  erythema  is not taken  into  account.  Positive  test   is 
considered  if  the  induration  exceeds  10mm , Negative  if  it  is < 5mm  
and doubtful  if  it  is 6-9mm. 
POSITIVE TEST:  suggestive  of  recent  or  past  infection  of  the  
tubercle   bacilli   or  BCG  vaccination. It  is  due  to  hypersensitivity  to  
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tubercular  protein. It  becomes  positive  only  after  4 to  6 weeks after  
infection  or  vaccination. 
NEGATIVE TEST:  excludes  tuberculous   infection. 
But it does  not  always  rule  out  tuberculosis  . 
FALSE NEGATIVE:  occurs in 
 immunosuppression  
 convalescence from viral infections 
  severe  malnutrition   
 lymphoma  , sarcoidosis 
 improper injection techniques 
 atypical Mycobacterial infection 
Tubercular  testing  also   used   in   the  diagnosis of  :  
 active   infection   in   infants  and  young  children 
 measuring TB prevalence in community 
RADIOLOGICAL INVESTIGATIONS: 
X -  RAY NECK:  look for calcification 
(34) 
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X – RAY CHEST :  to  rule  out  pulmonary  tuberculosis 
FNAC OF LYMPH NODE: 
Smear  is  stained  by  Ziehl  nelson  technique,  at least  10000 cells are 
required   for positive  result .Histopathology  shows : Tubercle  (granuloma) 
comprising   area of  caseation  surrounded  by  epitheloid histiocytes  ,giant 
cell,  lymphocytes and  plasma  cells. 
BIOPSY OF THE LYMPH NODE: 
It  is  a superior and  reliable  investigation  for  confirmation  of  diagnosis . 
MACROSCOPIC FEATURES: 
 EARLY STAGE: Translucent and grey  patches 
ADVANCED STAGE: opaque  and  yellow  due to  caseation 
MICROSCOPIC FEATURES:
(35) 
At early stage ,it shows epitheloid cells and giant  cells  with  peripheral  nuclei. 
At the end of  first week  lymphocytes  with dark nuclei and scanty cytoplasm . 
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at the end  of third  week  caseation occurs  at  the  centre  with  surrounding  
epitheloid  and  giant  cells  , around  which  are  lymphocytes  and  plasma  
cells . 
CULTURE: 
Lowenstein  Jensen  media  is  used  for  culture  . It  takes  6 weeks  for  
positive  culture.  Serenity medium takes  5  days  . Middle  brook 7H12  and  
7H13  (BACTEC 12B AND 13B) are most  sensitive culture media .BACTEC 
is an automated method  which provides  result  in 4  days , radioactive C14  
labelled  broth  culture  is  used. mycobacteria metabolises the culture  to  
liberate   radioactive  co2. 
SEROLOGY: 
Passive  hemagglutination  may  be  positive  in advanced  disease  only  and  
negative in  early  stage  , but  no  serological  investigation is  diagnostic  of  
pulmonary  tuberculosis  . 
(36) 
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SPUTUM FOR AFB : 
Three samples are  taken . First  and  third  day  sample  are  spot  samples  
.Second  day  sample  is  a early  morning  sample  .Smear  stained  by  Ziehl  
nelson method  . Atleast  2  smear  positivity  is  required  to  declare  positive  
result. Smear  is  positive only  when there is  > 1-9 bacilli /  100 field. 
MOLECULAR TESTING : 
PCR   testing   is a very  fast  method  . It  is used  to  demonstrate  
Mycobacterial  DNA fragments .It is  a  very  useful  test  in   a suspected  case  
of  Mycobacterial  cervical  lymphadenitis . 10  microorganisms  are  sufficient  
for  positive   PCR . PCR testing  can also  be  done  on  the  FNAC or  biopsy  
smear and  hence  the  need  for  open  biopsy  is  reduced.  Sensitivity  of  the 
test is  43 to 84% . specificity  is 75 to  100%.  PCR  is  done  in the  smear  and  
culture  negative  cases. 
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IMMUNOPROPHYLAXIS  
BACILLE CALMETTE GUERIN – ( BCG )  was  identified  by Calmette and  
Guerin (1921). It is  a  live  attenuated  vaccine ,
(37)
  available  in a  freeze dried  
form   which  is  stable  compared  to  liquid .It  is given  intradermally  at  birth 
in  infants . In  developing  countries ,it  is given  for  children   under  15  years.  
It contains  Mycobacterium  bovis  strain . It  is  attenuated  by  239  serial  
subculture  in  glycerine  bile  potato  medium  for  a  period  of  13  years. It 
induces  delayed hypersensitivity  reaction,  hence  shows  positive  tuberculin  
reaction. It  provides  immunity  for  10  to 15  years. Natural  TB infection  also  
provides  immunity  for  the  same  duration  but  there  is progression  of  
disease  when  there  is  reactivation  but this  does  not occur  in  immunization. 
EFFICACY: 
 It  varies  between  80%  to  no  immune  response .It  depends  on  various  
factors  .  
 prevalence  and  virulence of  infection 
 type  and  potency  of  the  vaccine  used. 
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 Age  and  nutritional  status  of  the  individual. 
COMPLICATIONS:
(38) 
LOCAL: abscess ,  indolent  ulcer ,  keloid  , tuberculids – it is  satellite  nodule 
developed  adjacent to  vaccinated  site,lupus  vulgaris  ,lupoid  reaction . 
REGIONAL:  axillary  lymphadenitis or  abscess of  the  lymph  node. 
SYSTEMIC: fever  ,mediastinal  lymphadenitis , erythema  nodosum  , otitis  
media  , fatal meningitis  in  rare cases. 
Vaccination  confers  immunity  to  skeletal  , meningeal  and  military  
tuberculosis.  It  does  not provide  immunity  for  pulmonary TB especially  in  
infants  and  young  children , but  the  disease  takes  milder  course. 
DIFFERENTIAL DIAGNOSIS: 
 
Cervical lymphadenitis can be due to: 
 
 Viral 
 
 Bacterial- tubercular, atypical tuberculosis, syphilis, brucellosis, non- 
 
Specific 
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 Fungal-fungal granuloma 
 
 Organic-drug reaction, reactive follicular hyperplasia 
 
 
 Malignancy-which includes primary (Hodgkin‟s lymphoma,  
 
lymphosarcoma) and secondary (with primaries in the neck, thorax and  
 
abdomen) 
 
 Others 
These  can produce both  acute or  chronic lymphadenitis similar to 
tuberculosis. 
 
SARCOIDOSIS: 
Granulomatous lesions are commonly seen in the lungs, lymph nodes, skin, eye,  
liver, spleen, salivary glands, heart, skeleton and nervous system. The lymph  
node involvement is restricted usually to the superficial group, about 2-3cm in  
size, non-tender and no periadenitis. The lymph node involvement in  
sarcoidosis is differentiated from tuberculous lymph node by the absence of  
caseation. Mantoux test is negative and diagnosis is confirmed by biopsy and  
Kveim test. 
 
CAT- SCRATCH DISEASE: 
Caused by B.henselae where initially there is enlargement of either the axillary  
or the cervical lymph nodes. Primary skin lesion is indicated by a red papule  
appearing between 7-12 days following contact. Diagnosis is confirmed by skin  
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testing and biopsy of lymph nodes which reveals lesion of histiocytic  
proliferation and follicular hyperplasia. 
INFECTIOUS MONONUCLEOSIS: 
(39) 
Otherwise termed the GLANDULAR FEVER. 
Rickettsia group of organisms causes this disease which is characterised by  
fever, cervical lymph node enlargement (posterior triangle group of lymph  
nodes are equally involved) which is painful and tender, sore throat,  
splenomegaly, hepatomegaly and skin rashes. Diagnosis is confirmed by blood  
investigations which include Paul-Bunnel test where there is an increase of  
agglutinins for sheep RBCs during the acute phase of the disease and atypical  
lymphocytosis. Epstein-Barr virus antibodies are detected by  
immunofluorescence and ELISA. 
 
SYPHILITIC LYMPHADENITIS: 
PRIMARY STAGE: 
Genital chancres and groin nodal enlargement. 
 
SECONDARY STAGE: 
Generalised involvement of the lymph nodes especially the epitrochlear and  
occipital group of lymph nodes which are painless, discrete, firm and shotty. 
 
TERTIARY STAGE: 
Lymph nodes are rarely involved. 
Presence of Treponema pallidum in dark ground illumination from the primary  
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lesion and positive W.R and Kahn tests confirms the diagnosis. 
Specific tests includes FTA-ABS, MHA-TP. 
(40) 
BRUCELLOSIS: 
Otherwise termed the UNDULANT FEVER. 
Brucella are small, gram negative, non-motile coccobacilli which presents with  
fever, malaise, headache, myalgia and GI disturbances with enlargement and  
tenderness of the spleen, liver and lymph nodes. Blood investigations which 
 shows hypochromic anaemia,leukopaenia, agglutination and culture of the 
 tissue confirms the diagnosis. Lymph node biopsy reveals features of either  
tuberculosis or Hodgkin‟s disease. ELISA is used to detect either the IgG or the  
IgM antibodies. 
TULAREMIA: 
It is highly infectious disease usually occurring in the farmers, hunters, 
 butchers, people who handle the contaminated skin or the internal organs of the 
 infected rabbits. It  presents with symptoms like headache, feeling of cold 
 and pyrexial episode and resembles a plaque with ulcer at the site of infection, 
 enlargement of the regional lymph nodes where it becomes indistinguishable 
 from tuberculosis showing caseation, necrosis, epitheloid and giant cell 
 formation. The disease is caused by Pastuerella tularaemia. 
(41)
 Diagnosis is 
 confirmed by the isolation of the organisms from the guinea pigs and rising 
 titre of the agglutinins against tularaemia in the serum. 
TOXOPLASMOSIS: 
It is caused by an intra cellular parasite Toxoplasma gondii. It exists in 4 forms  
which includes cerebrospinal, lymphatic, exanthematous and the latent form out 
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 of which lymphatic form is important. It presents with the enlargement of one  
or more group of lymph nodes with fever of several weeks of duration and  
marked constitutional symptoms. Diagnosis is confirmed by complement  
fixation tests, neutralising antibody test and toxoplasmosis skin test. 
 
FUNGAL: 
A chronic granulomatous  process with/ without caseation necrosis is noted.  
Organisms like coccidiodomyces and blastomyces are identified with  Pas  
Grithley and Gomori methenamine silver. 
 
HODGKIN’s DISEASE: 
Lymph nodes are markedly enlarged with hard rubbery consistency where more 
 than one group is involved in different regions of the body with no features of 
 matting and periadenitis. Splenomegaly is present. Nodal enlargement in the 
 axilla and mediastinum will occur in the course of several weeks or months.  
 As in tuberculosis,  non-specific inflammation or in secondary deposits, the  
nodes do not break or suppurate but in this case the nodes break and suppurate. 
 Biopsy gives conclusive evidence. 
Severe pain at the site of the disease after ingestion of  alcohol, pyrexia,  
leucocytosis, eosinophilia are the common features. 
 
SECONDARY CARCINOMA: 
Due to the lymphatic metastasis, there is enlargement of the cervical group of  
lymph nodes in the elderly. The primary carcinoma is most often in the  
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mouth(tongue), lips,  pharynx etc.,Malignant melanoma  commonly leads to the 
 secondary involvement of the lymph nodes. 
TREATMENT: 
(42) 
CHEMOTHERAPY: 
Treatment of tuberculous lymphadenitis includes either medical or surgery but 
 with the advancements of short course chemotherapy where the duration of 
 therapy has reduced from 18months to 6months and a cure rate of 95%, the role 
 of surgery is diminishing. Treatment is based on the WHO guidelines, where 
 the National Tuberculosis Programme worldwide follows DOTS approach 
 which provides intermittent chemotherapy for patients with tuberculous 
 lymphadenitis. Cat I treatment is for those who are smear positive tuberculous 
 lymphadenitis with pulmonary involvement or are severely ill. 
Anti-tuberculous treatment was introduced in the early 1950s. The tuberculous 
 research centre in Chennai in 1990 reported results of a supervised short course 
 intermittent chemotherapy (6moths) consisting of streptomycin, rifampicin, 
 isoniazid, pyrazinamide 3times a week for 2 months followed by streptomycin 
 and isoniazid twice a week for 4 months on OP basis in children with 
 lymph node tuberculosis and a favourable clinical response was noted at the  
end of the treatment. Hence in children, short course chemotherapy of 6 months  
is effective in treating tuberculous lymphadenitis. 
FACTORS WHICH MAKES TUBERCULOSIS DIFFICULT TO TREAT: 
 Caseation, an unique feature of tuberculosis, keeps the disease dormant 
 
 where the organisms multiply preventing the contact of the environment 
 
 of the body with the chemotherapeutic drugs. 
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 Fibrosis reducing the blood supply. 
 
 The poor penetrating effect of the chemotherapeutic agents which allows 
 
 the tubercle bacilli to remain viable and multiply even after being 
 
 ingested by the macrophages. 
 
 Quick development of the resistance when administered improperly. 
 
 Prolonged duration of the treatment. 
 
 Expensive treatment. 
 
 
ANTI-TUBERCULOUS DRUGS: 
 
BACTERICIDAL DRUGS:  
 
ISONIAZID (1952): 
 
ISONICOTINIC ACID HYDRAZIDE 
 
The drug acting on both the extra cellular and intra cellular bacilli kills the fast  
multiplying organisms while the quiescent ones are only inhibited. It is  
considered the most effective drug against Mycobacterium tuberculosis. 
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MECHANISM OF ACTION: 
Exact mechanism not known but probably due to the inhibition of a unique fatty 
 acid component of a bacterial cell wall, MYCOLIC ACID. 
(43) 
ABSORPTION AND RATE: 
The drug penetrates through the caseous material with a peak plasma  
concentration of 3-5mg/ml developing 1-2hours following an oral ingestion. 
 Being given orally/ parenterally, the drug is readily absorbed maintaining the 
 blood level and therapeutic concentration in the CSF. The drug is metabolised 
 by the liver by acetylation 75-95% of the dose is excreted in the urine in 
 24hours. 
DOSAGE: 
Daily dose of the drug is 5mg/kg with a maximum of 300mg and in children 
 <4years , dose is 10mg/kg/day. 
Tablet: 50mg, 100mg, 300mg. 
Syrup: 10mg/ml. 
Injection: 10mg/ml. 
Pyridoxine added in a dose of 10-50 mg/day to prevent peripheral neuritis 
 caused due to ISONIAZID.  
Side effects includes hepatitis, rash, psychosis, acne and fever. 
RIFAMPICIN: 
It is a semi synthetic derivative of rifamycin-B. 
This  complex macrocyclic antibiotic is  derived from Streptomyces  
mediterranei. 
 Affects both the extra-cellular and intra-cellular bacilli and acts on 
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 slowly/intermittently dividing organisms. 
MECHANISM OF ACTION: 
Inhibits DNA dependant RNA polymerase suppressing the initiation of chain 
 formation in RNA synthesis. 
ABSORPTION AND FATE: 
Penetrates all the body fluids, absorbed orally with a peak concentration in 2- 
4hours and therapeutic levels in CSF with rapid elimination in bile by  
deacetylation. 
DOSAGE: 
>50kg – 450mg/day  (44) 
Children – 10mg/kg/day. 
CAPSULE: 
150, 300, 450 and 600mg. 
ADVERSE REACTIONS: 
Flu like symptoms (fever, chills, headache and malaise), GI disturbances  
(nausea, vomiting and abdominal cramps), flushing, pruritis, rash, hepatitis, 
 orange pink discolouration of body secretions. 
STREPTOMYCIN: 
Till 1952,it was the only effective drug available to treat tuberculosis. It crosses  
the placenta and fetal serum levels are half of those in the maternal blood  
reaching a peak concentration of 1hour when administered i.m. 
It is excreted by glomerular filtration and hence the dosage should be titrated in 
 renal failure. 
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DOSAGE IN VARIOUS AGE GROUPS: 
1gm       - young individuals 
0.75gm  -40-60 years age group 
0.5gm    ->60years. 
SIDE EFFECTS: 
Ototoxicity (vestibular damage), anaphylaxis, renal tubular damage, blood 
 dyscrasias. 
PYRAZINAMIDE: 
It is the synthetic pyrazine analogue of nicotinamide. It is lethal to the intra 
 cellular bacilli exhibiting bactericidal activity only in acidic pH. Interacts with 
 the fatty acid synthase and inhibits the mycolic acid synthesis. It is well 
 absorbed from the GIT and widely distributed. Oral administration of 1gm 
 produces plasma concentration of 45mg/ml at 2hours. Drug is excreted by 
 glomerular filtration. The drug is hydrolysed and hydroxylated to 5-OH 
 pyrazinoic acid which is the major excretory product available as 500mg/ 
 750mg tablets. Daily dose is 20-35mg/kg orally. Maximum dose is 3gm/day 
 regardless of the weight. Side effects includes hepatotoxicity, gout, arthralgias, 
 flushing, rashes and fever. 
ETHAMBUTOL: 
It is a bacteriostatic drug but in high concentrations it is bactericidal. The exact 
 mechanism is not known. It  inhibits the arabinosyl transferases involved in  
arabinogalactan synthesis and interferes with the mycolic acid incorporation 
 into the Mycobacterial cell wall. About 75-80% of the oral drug is absorbed  
 from the  gastrointestinal tract and the peak plasma concentration is after         
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 2-4hours.  
The half life of the drug is 3-4hours. Two thirds is excreted in the urine and  
15% is excreted in the form of the metabolites. 
Tablet of 400mg and 800mg are available. Usual dose is 25mg/kg/day. Side  
effects includes ocular toxicity, diminished visual activity, hyperuricaemia,  
fever and rash. 
DIFFERENT REGIMENS: 
6 MONTH REGIME: 
Initial phase of 2months – Ethambutol/Streptomycin +  Isoniazid + Rifampicin 
 + Pyrazinamide 
Continuation phase of 4months – Isoniazid + Rifampicin 
9 MONTH REGIME: 
Initial phase of 2 months – Ethambutol/Streptomycin + Isoniazid + Rifampicin 
Continuation phase of 7months – Isoniazid +Rifampicin  
12 MONTH REGIME: 
STM 1gm i.m for 3months with a total dose not exceeding 45gms. 
It is given as follows: 
Every day for the first 2weeks, every other day 1month,  and every 3days for  
1.5months. 
RIF (600mg/day, p.o.) for 6months 
INH (300mg/day p.o.) for 12 months or 18 months. 
EMB (900mg/day p.o) for 12 months or 18 months. 
PARA- AMINO SALICYLIC ACID: 
This drug is rarely used with the advancement of short course chemotherapy. It 
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 is not used because of the bulk and the unpleasant sensation. 
THIOACETAZONE: 
It is abandoned in developing countries but it is also used in some developing  
countries because it is cheap. It is available as 150 mg tablet in combination 
 with Isoniazid. Usual dose is 150mg/day. Side effects are hypersensitivity 
 reactions as Steven Johnson syndrome which includes the symptoms such as  
fever, rash, joint pain. This is a severe life threatening complication. 
OTHERS: 
Cycloserine, Kanamycin, Ethionamide, Capreomycin are the second line drugs. 
 
NEWER ANTI-TUBERCULAR DRUGS: 
The fluoroquinolone group of drugs are quite effective out of which ofloxacin is  
most effective which showed a therapeutic effect on mice. Other drugs like  
Sparfloxacin and Fleroxacin demonstrate anti tubercular activity. Rifabutin, a   
drug belonging to rifamycetins is an effective drug. These drugs have been  
effective in experimental animals and human cases but is not recommended for  
general use. 
Multi- drug resistant tuberculosis MDR-TB is defined as tuberculosis resistant  
to at least Isoniazid and Rifampicin. When multi-drug resistance to the drugs 
 involves at least one drug in each group then it is termed as the extensive drug  
resistant tuberculosis XDR-TB. MDR-TB can also involve the second line  
drugs which includes the fluoroquinolones and the injectable drugs. Treatment  
of MDR-TB must be done on the basis of sensitivity testing. 
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RISK FACTORS FOR MDR-TB INCLUDES: 
 Failed TB treatment 
 
 Failure to respond to TB treatment 
 
 Relapse following standard TB treatment 
 
 Previous incarceration 
 
 HIV infection 
 
 
If the treatment is for a suspected case of MDR-TB, the patient is started  
on SHREZ (Streptomycin+ Isonicotine hydrazine+ Rifampicin+ Ethambutol+  
pyrazinamide) + MXF + Cycloserine until the report of the sensitivity testing is 
 received. 
 
ASSESSMENT OF PROGRESS: 
 
Improvement of  ESR is of prognostic value. 
Periodic check-up has to be done. If the patient shows no improvement when 
 under treatment then the doctor should find the cause and treat accordingly. 
 Before stopping the treatment, it is best to investigate twice since staring the 
 treatment all over again is difficult. 
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Treatment categories in DOTS chemotherapy in India: 
                           Table 1 – Categories in DOTS chemotherapy 
TREATMENT 
CATEGORY 
TYPE OF THE 
PATIENT 
TREATMENT 
REGIMEN 
CATEGORY I New sputum smear- 
positive 
2 (HRZE)3 
4 (HR)3 
Seriously ill sputum 
smear-negative 
Seriously ill extra-
pulmonary 
New sputum smear-
negative, not seriously ill 
New extra- pulmonary, 
not seriously ill 
CATEGORY II Sputum smear positive 
Relapse, failure and 
default 
2 (HRZES)3 
1 (HRZE)3 
5 (HRE)3 
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The number before the letters in the treatment regimen indicates the number of 
months of treatment. The number after the letters indicates the number of doses 
per week. 
H – Isoniazid (600mg) 
R – Rifampicin (450mg) 
Z – Pyrazinamide (1500mg) 
E – Ethambutol (1200mg) 
S – Streptomycin (750mg) 
Patients more than 60kg receive an additional dose of rifampicin 150mg. 
                        ROLE OF SURGERY 
The  role of surgery is decreasing with the advent of effective anti-tubercular  
therapy. 
 
Surgical procedures are ; 
1. Biopsy. 
 
2. Excision 
 
3. Aspiration  
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4. Excision of sinus and scar. 
 
5. Curettage. 
 
6. Excision of cold abscess. 
 
7. Tonsillectomy. 
BIOPSY:  
It is usually done for superficial mobile lymph node. Biopsy is for confirmation  
of  diagnosis before starting the short course chemotherapy. 
 
EXCISION: 
Excision of a mobile node with an intact capsule shortens the duration of 
 treatment, lessens the chance of recurrence and disfigurements and is 
 considered only when patient is not responding to chemotherapy. The lymph  
node should be removed in toto.  
Excision is considered in case of matted nodes, cold abscess, discharging sinus 
 and in patients who respond well to  anti-tubercular drugs.  
Contradiction to excision is the presence of secondary infection , multiple node 
 involvement, tender nodes and the presence of active lesion elsewhere in the 
 body. 
Excision is not a contraindication in children but is better avoided in children. 
ASPIRATION:  
The presence of a big cold abscess, the chances of bursting open of the abscess, 
 the presence of the disease in the acute phase are indications of aspiration from 
 a non-dependent area with wide bore needle. Aspiration can also be  repeated 
 which makes excision easy.  
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INCISION AND DRAINAGE:  
It facilitates the spread of infection. 
CURETTAGE:  
Curettage is considered when the lesion is close proximity to the nerve or in the  
presence of extensive skin necrosis. It has 70% cure rate. 
OPERATION: 
The presence of large, matted glands mandates removal but the removal is  
dangerous  if the node is attached to the wall of  IJV. The nodes are removed  
through a horizontal neck incision. If the bleeding of  IJV is encountered, it is  
stopped either by finger pressure or by dissection of the vein above and below  
the matted glands, ligation and excision of the segment of the vein along with 
 the glands.   
Functional neck dissection involves fat removal , associated lymph nodes in the  
posterior and anterior triangles of the neck and is performed only when the  
glands and vein is involved extensively.  The sternocleidomastoid muscle, 
 accessory nerve and the IJV are to be preserved. 
Removal of the gland should be followed with chemotherapy, otherwise sinuses  
form with persistent drainage and scars. Mostly the infection is from the  
ipsilateral tonsil , which mandates the removal of tonsil also.   
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MATERIALS AND METHODS. 
The cases used for this study consists of elaborate study of 70 cervical 
tubercular lymphadenitis patients, diagnosed and treated at Government 
Kilpauk medical college , Chennai during the period  August 2013 to August 
2014. The patients were mainly from in and around Chetpet area.  
The paper consists of seventy cases selected conveniently. For statistical 
evaluation the data from my study is compared with that of data from literature. 
METHODS: 
The case details were recorded as depicted in the proforma. The data are 
enclosed in the master chart for analysis. 
INCLUSION CRITERIA: 
1. Patients who were above 12 years of age and also confirmed to have 
cervical tubercular lymphadenopathy both clinically and pathologically.  
2. Patients who gave consent for investigations and willing to undergo 
surgery if required.  
EXCLUSION CRITERIA: 
1. Patients less than 12 years of age. 
2. Pregnant women with cervical lymphadenopathy. 
3. Psychiatric patients. 
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4. Patients  not willing to undergo investigations and surgery if required. 
The patients are concluded to have cervical tubercular lymphadenopathy 
based on history, clinical examination and confirmed by either FNAC or 
histopathological examination.  
Anti-tubercular chemotherapy was started only after confirmation of the 
diagnosis. 
Investigations such as Hb%, total count and differential  count  , ESR and 
chest X-ray were done routinely. X-ray chest was done to rule out coexisting 
pulmonary lesion.  
Haematinics were given to anaemic patients to improve the general status. 
For the patients who underwent surgery , the parts were prepared one night 
before and kept on nil per oral for 12 hours . After getting the written 
consent from patients, they were operated under general anaesthesia. 
Antibiotics were given one hour before surgery prophylactically.  
Follow of the patients was done from  first post-operative day to the day of 
discharge. Once the diagnosis was confirmed the patients were advised to 
take short course anti-tubercular therapy for 6 months. 
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RESULTS 
Table 2- Incidence of tuberculous cervical lymphadenitis 
 
Total no of cases Total no of cases with 
tuberculous cervical 
lymphadenitis 
Percentage  
100 70 70 
  
Graph 1 – Showing incidence of tuberculous cervical lymphadenopathy  
 
 
The most dreadful disease in India is tuberculosis which is the most common 
cause of cervical lymphadenopathy accounting for about 70 cases out of the 100 
cases in the present study. Other causes of cervical lymphadenopathy were non-
specific lymphadenitis (28cases), lymphoma (2cases). 
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                                          Table 3 – Age Incidence 
      Age Group (years) 
 
            No of cases              Percentage  
              11-20 
 
                  7                    10 
              21-30 
 
                35                    50 
              31-40 
 
                14                    20 
              41-50 
 
                 7                    10 
              51-60 
 
                 7                    10 
              61-70 
 
                 -                     - 
             TOTAL 
 
                70                   100 
 
Graph 2 – Showing age incidence 
 
 
 
The disease occurs mostly in the age group of 21-30 years. No cases were  
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reported in the age group of 61-70 years in the present study. The youngest in 
the present series is 12 years old. 
Table 4– Sex Incidence 
 
Sex  No of cases Percentage 
 
Female  
 
42 60 
Male 
  
28 40 
 
Graph 3 – Showing sex incidence 
 
 
 
There is a higher incidence in females. There are 28 male cases and 42 female  
cases according to the present study with a female to male ratio of 1.5:1. 
 
 
Female  42
60%
Male  28
40%
Sex Incidence
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Table 5 – Socio Economic status 
 
Socio economic status 
 
No of cases Percentage  
Lower 
 
63 90 
Middle 
 
7 10 
Upper  
 
- - 
 
Graph 4 – Showing socio – economic incidence 
 
 
Based on Kuppusamy‟s socio – economic scale of classification, study cases  
were divided into lower, middle and upper socio-economic status. Tuberculosis  
mainly affected lower group of people comprising about 90% of cases. 
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Table 6- Geographical Distribution 
 
 
Area  
 
No of cases Percentage  
Rural  
 
49 70 
Urban  
 
21 30 
 
 
 Graph 5 – Showing geographical distribution 
 
 
 
Tuberculous cervical lymphadenitis is more common in people living in the  
rural population comprising about 60% of the population.  
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Table 7 – Clinical Presentation 
 
Symptoms  
 
No of cases  Percentage  
Swelling  
 
70 100 
Pain  
 
7 10 
Fever  
 
14 20 
Weight loss 
 
7 10 
Cough  
 
7 10 
Sinus  
 
- - 
 
 
Graph 6 – Showing clinical presentation 
 
All the 70 cases (100%) presented with swelling in the neck. 7 cases (10%)  
presented with pain, 7 cases (10%) presented with weight loss and 7cases 
 presented with cough. About 14cases (20%) presented with fever. 
0
10
20
30
40
50
60
70
80
90
100
Swelling Pain Fever Weight 
loss
Cough Sinus 
Symptoms 
Symptoms 
95 
 
 
Table 8– Duration of the disease 
 
Duration  
 
No of cases Percentage  
< 3months 
 
49 70 
>3 months 
 
21 30 
 
49 cases (70%) presented within the duration of 3 months. 
 
 
Table 9– group of lymph nodes involved 
 
 
Lymph node group 
 
No of cases Percentage  
UDC 
 
42 60 
LDC 
 
                    8 11.4 
SM 
 
3 4.3 
PT 
 
14                   20 
MULTIPLE 
 
3 4.3 
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                    Graph 7 – Showing group of lymph nodes involved 
 
 
Most commonly affected is the upper deep cervical group of lymph nodes 
involved in about 42cases (60%). Posterior triangle group of nodes were 
involved in about 14cases (20%). 8cases (11.4%) presented with the lower deep 
cervical involvement. Submandibular and multiple nodal involvement were the 
least constituting about 3%. 
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Table 10– Side of the lymph nodes involved 
 
Side involved 
 
No of cases Percentage  
Right  
 
24 34.3 
Left  
 
40 57.1 
Bilateral  
 
6 8.6 
 
Left side nodes (40cases) are most commonly affected in tuberculosis than the 
right side (24 cases). 
Table 11– Lymph node character 
Lymph node character 
 
          No of cases Percentage  
Firm  
 
49 70 
Soft  
 
21 30 
Discrete   
 
54 77.1 
Matted  
 
16 22.9 
Fixity  
 
- - 
Sinus  
 
- - 
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Graph 8 – Showing lymph node character 
 
Firm lymph nodes were noted in about 49 cases (70%). 77.1% of the cases  
presented with discrete nodes. Matted nodes were noted in 16 cases (22.9%). 
None of them presented with fixed nodes or sinus according to the present 
study. 
Table 12 - Investigations 
         Investigations  
 
          No of cases             Percentage  
Raised ESR 
 
                40                 57.1 
Positive chest X-ray 
 
                 6                  8.6 
Sputum for AFB positive 
 
                 4                  5.7   
FNAC/Excision biopsy 
 
                70                 100 
Tuberculin test 
 
                19                 27.1 
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Graph 9 – Showing Investigations 
 
 
40 cases presented with raised ESR (57.1%, >30mm at the end of 1hour). All 
cases were confirmed by FNAC/Excision biopsy (100%). Features of 
pulmonary tuberculosis on chest X-ray were positive in 6cases and sputum AFB 
was positive in 4 cases. Tuberculin test was positive in 19 cases (27.1%). 
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Table 13– Results of FNAC and Excision Biopsy 
 
Investigations  Caseating granuloma 
 
Inconclusive  
No of 
cases 
 
Percentage  No of 
cases 
Percentage  
FNAC 
 
58 82.9 12 17.1 
Excision 
Biopsy 
 
12 100 - - 
 
Fig 9 – Presentation of a tuberculous cervical lymph node 
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Fig 10 – Cold aspirate 
  
All the 70 cases studied in the present series were put on short course 
chemotherapy after thorough confirmation by FNAC or histopathological 
examination of the excised lymph node. 58 cases were confirmed by FNAC 
which revealed caseating granuloma. 12 cases (17.1%) were inconclusive and 
these 12 cases were subjected to excision biopsy which showed caseating 
granuloma. None of them presented with cold abscess. 
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DISCUSSION 
70 cases of tuberculous cervical lymphadenitis in the present series is compared  
with the other studies in the literature. 
 
Table 14– Comparison of Age incidence with the other studies 
 
               Series                         Age in years 
 
11-20 21-30 31-
40 
41-
50 
51-
60 
61-
70 
Present series  
 
7 35 14 7 7 - 
Kumar Biswas series (45) 
 
10 9 3 3 - - 
Muhammed MM series(46) 
 
44 31 11 8 2 - 
 
From the above table, it is clear that the most commonly affected population are  
in the age group of 21-30 years. It is compared with the other studies in the  
same table. 
In Kumar Biswas study of 30 cases, 9 cases are in the age group between 21-30 
 years. In Muhammed Mudassar Majeed study of 96 cases, 31 cases are in the  
age group of 21-30 years. In the present series studied, 35 cases are in the age  
group of 21-30 years which is almost equal to the studies in the literature. 
In this age group, the lymphatics play an important role with the lymph nodes  
acting as a powerful second line of defense against the infection. Poor 
 nourishment with malnutrition acts as a predisposing factor in this age group. 
None of them were in the age group of 61-70 years in  the present study. The 
youngest in the present series is 11 years and the oldest is years. 
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Table 15 – Comparison of sex incidence with the other studies 
 
          Series               Male 
  
             Female  
No of cases 
 
Percentage  No of cases Percentage  
Present series 
 
28 40 42 60 
Kumar Biswas series 
 
11 36.6 19 63.4 
Muhammad MM series 
 
38 38 62 62 
Salman M et al study(47) 
 
21 42 29 58 
 
 
In the present study, the female to male ratio is 1.5:1 which is compared with 
the other series available in the literature. The ratio according to the Kumar 
Biswas study is 1.73:1 whereas in Muhammad Mudassar Majeed series it is 
1.63:1. The present study is quite similar to the Salman M et al study where the 
ratio is 1.4:1. 
 
The reason behind the female preponderance of the disease is due to the under 
nutrition, repeated and early pregnancies etc., 
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Table 16 – Comparison of socio – economic status in various studies 
 
 
       Series     Low SES 
 
  Middle SES      High SES 
No of 
cases 
 
Percentage  No of 
cases 
Percentage  No of 
cases 
Percentage  
Present series 
 
 63 90 7 10 - - 
Kumar 
Biswas series 
 
18 60 9 30 3 10 
 
 
The incidence of tuberculous cervical lymphadenitis is more common in the low 
socio- economic status which accounts for about 90% as compared to 60% in 
the Kumar Biswas series. 
Overcrowding, poor ventilation, poverty, malnutrition and unhygienic 
environment are the predisposing factors for the increased incidence in the low 
socio-economic status  group. 
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Table 17 – Comparison of clinical presentation in various studies 
 
Symptoms  
 
Present series 
 
Jha BC et al study 
No of cases 
 
Percentage  No of cases  Percentage  
Swelling 
  
70 100 53 94.6 
Pain  
 
7 10 4 7.3 
Fever  
 
14 20 6 10.7 
Weight loss  
 
7 10 8 14.3 
Cough  
 
7 10 6 10.7 
Sinus  
 
- - 3 5.3 
Others  
 
- - 6 10.7 
 
The most common symptom with which the patient presents to the hospital is 
neck swelling which is seen in almost all the cases i.e. about 100%. 20% cases 
presented with fever, 10% cases presented with pain, weight loss and cough 
each. These results were compared with the Jha BC et al study which are almost 
similar to the present study which accounts for about 94.6% cases presenting 
with swelling, 7 cases presented with pain, weight loss and cough each.14 cases 
presented with fever. 
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Cough is due to the upper respiratory tract involvement and is not a specific 
feature of tuberculous adenitis. 
Pain is due to the stretching of the capsule or the deep fascia of the neck by the 
enlarging lymph nodes. Pain is more if superadded secondary infection is 
present. 
General symptoms like fever, loss of weight etc., are not specific for tubercular 
adenitis. 
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Table 18 – Comparison of Lymph node characters in various studies 
 
Lymph node 
character 
Present series Salman M et al 
study 
Indian Council of 
Medical Research 
Study (48) 
No of 
cases 
 
% No of 
cases 
% No of 
cases 
% 
Firm consistency 
 
49 70 33 66 116 65.5 
Soft consistency 
 
21 30 6 12 - - 
Discrete  
 
54 77.1 9 28 79 54.1 
Matted  
 
16 22.9 36 72 81 85.3 
Fixity  
 
- - - - 34 79.1 
Sinus  
 
- - 3 6 - - 
 
Lymph node involvement is discrete in 54 cases (77.1%) and matted in 16 cases 
(22.9%). Lymph nodes are firm in consistency in 49 cases (70%) and soft in 
consistency in 21 cases (30%). The results of the present series are compared 
with those in the Salman M et al study and ICMR study as quoted in the table. 
ICMR study included more number of cases and hence the results were higher 
in it. In Salman M et al study, 66% of cases had nodes which were firm in 
consistency and 12% of cases presented with nodes which were soft in 
consistency. 72% (36 cases) presented with matted nodes and 28%  (9 cases) 
presented with solitary nodes. 6% had sinus. None of the cases presented with 
fixed nodes or sinus in the present study. 
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Table 19 – Comparison of groups of lymph nodes involved in various studies 
  
Group of lymph 
nodes involved 
 
Present series in 
% 
Kumar Biswas 
study in % 
Maharjan M et al 
study in % (49) 
Upper deep  
Cervical 
 
60 33.3 16 
Lower deep 
cervical 
 
11.4 10 6 
Submandibular  
 
4.3 13.3 15 
Supraclavicular  
 
- 3.4 9 
Posterior triangle 
 
20 20 42 
Multiple  
 
4.3 20 - 
 
 
The upper deep cervical group of lymph nodes are most commonly affected in 
the present series accounting for 60% which is more when compared to the 
Kumar Biswas study and Maharjan M et al study. The submandibular and the 
multiple nodal involvement are the least accounting for 4.3% each. There is no 
supraclavicular involvement in the present series. In Maharjan M et al study, 
posterior triangle group of nodes are more commonly affected followed by the 
upper deep cervical group of nodes. 
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The tubercle bacilli are filtered at the nose, oral cavity, pharynx and tonsils and 
ultimately drain into the upper deep cervical group of lymph nodes and hence 
the lesions are produced here. The other portal of entry is the adenoids which 
drain into the lower deep cervical group of lymph nodes which accounts for 
about (11,4% cases) in the present study. Multiple nodal involvement is present 
in about 4.3% cases according to the present study. 
 
 
Table 20 – Comparison of associated pulmonary tuberculosis in various studies 
 
 Present series 
 
Maharjan M et al 
study 
Jha BC et al 
study(1) 
Total no of cases 
studied 
 
70 83 60 
Associated 
pulmonary 
tuberculosis in 
percentage 
 
5 14 16 
 
In the present series, about 5% cases had associated pulmonary tuberculosis 
which is about 14% in the Maharjan M et al study and 16% in the Jha BC et al 
study. 
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Table 21 – Comparison of investigations in various studies 
 
Series  Raised ESR in 
percentage 
Chest X-Ray in 
percentage 
FNAC/Excision 
biopsy in 
percentage 
Present series 
 
57.1 8.6 100 
Jha BC et al study 
 
100 16 100 
Maharjan M et al  
Study 
 
79 14 100 
 
Erythrocyte sedimentation rate was raised in 57.1% of the cases in the present 
series which is 100% and 79%  respectively in the Jha BC et al study and 
Maharjan M et al study. Chest x-ray showed features of tuberculosis in 8.6% of 
the cases which is 16% and 14% respectively in the Jha BC et al study and 
Maharjan M et al study. 
Fine Needle Aspiration Cytology was done in all the cases and found to be 
positive in all the cases which is the same as compared to the Jha BC et al study 
and Maharjan M et al study. 
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Table 22 – Comparison of results of FNAC and Excision biopsy in various  
studies  
 
Study series FNAC in % Excision Biopsy in % 
Caseating 
granuloma 
inconclusive 
Present series 
 
82.9 17.1 100 
Muhammad Mudassar 
series 
 
69 31 - 
Salman M et al study 82 - 18 
In the present series, FNAC revealed caseating granuloma in 82.9% of cases 
compared to 69% in Muhammad Mudassar series and 82% in Salman M et al 
study. FNAC showed inconclusive evidence in 17.1% of the cases in the present 
series. According to the Salman M et al study, excision biopsy revealed 
caseating granuloma in 18% of the cases. 
Table 23 -  Comparison of treatment given in various studies 
Treatment 
given 
Present series 
in % 
Salman M et 
al study in % 
Maharjan M 
et al study in 
% 
Jha BC et al 
study in % 
Excision 
biopsy 
 
17.1 18 4.8 7.14 
FNAC 
 
82.9 82 95 92.8 
ATT 
 
100 100 100 100 
Non-
dependent 
drainage 
 
- - - 3.57 
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 12 cases (17.1%) were subjected to excision biopsy of the affected lymph 
nodes according to the present study. 58 cases (82.9%) were diagnosed by 
FNAC alone. This result is similar to that of the Salman M et al study in which 
82% of the cases were diagnosed by FNAC alone and 18% of the cases were 
diagnosed by excision biopsy. In Jha BC et al study, FNAC proved effective in 
92.8% of the cases and excision biopsy was conducted in 7.14% of the cases. 
3.57% of the cases underwent non-dependent aspiration of the nodes according 
to the Jha BC et al study. In the present study, none of the cases were subjected 
to non-dependant aspiration. 
After confirmation of diagnosis, patients were put on Anti-tubercular drugs and 
were followed up. The cure rate was 100%. This result is also quite similar to 
that of the Jha BC et al study and Maharjan M et al study. 
Over the years, because of the advancement in medical science, chemotherapy 
is more effective and has almost limited the role of surgery to drainage of the 
cold abscess, excision of the residual lymph node mass or scars, excision biopsy 
of the affected lymph nodes. 
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FOLLOW UP: 
The cases which were put on anti-tubercular treatment were followed up  at an 
interval of about 1-2 months from the commencement of ATT to a period of 6 
months. During this period, cases were assessed by clinical examination and 
ESR examination. The decrease in the size of the swelling and the generalised 
improvement in the health status of the patients were studied and majority of the 
cases showed improvement within 4weeks of the start of the treatment. 
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CONCLUSION 
Historical aspects on tubercular cervical lymphadenitis has been reviewed. 
A brief description on the anatomy, physiology of the lymph nodes draining the 
neck, along with the distribution of the lymph nodes, with the aetiology, 
pathology, clinical aspects  and the type of treatment are discussed in detail. 
100 cases were taken, out of which 70 cases of cervical tuberculous 
lymphadenitis were studied, analysed in detail and the following conclusions 
were drawn. 
The incidence of tuberculous cervical lymphadenopathy was maximum in the 
age group of 21-30 years (35 cases-50%). The youngest in the study is 12years. 
The disease showed an increasing incidence in females as compared to the male 
patients with the female to male ratio being 1.5:1.  
It is more common in the lower socio-economic status people (90%).  
The disease shows increased incidence among the rural population which 
accounts for about 70% of the cases.  
All the 70 cases presented with the complaint of swelling in the neck. 14 cases 
presented with fever, 7 cases presented with pain, weight loss and cough 
respectively.  
The lymph node involvement was discrete in 77.1% of the cases and matted in  
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 22.9%  of the cases. 70% patients had firm consistency of the lymph nodes.  
The upper deep cervical nodes were involved in 60%  which was the most  
common lymph node involved in tuberculous cervical lymphadenopathy. 
57.1%  presented with raised ESR . 8.6%  had features suggestive of pulmonary 
tuberculosis on chest x-ray. 82.9%  showed caseating granuloma on FNAC. 
FNAC was inconclusive in 17.1% of the cases who were then subsequently 
subjected to Excision Biopsy which proved positive for tuberculous cervical 
lymphadenopathy. Tuberculin test was positive in 27.1% of the cases. 
The patients were then categorised as Category I or Category II patients and 
were put on Anti-tubercular treatment based on the histopathological 
(FNAC/Excision Biopsy) reports and were followed up for a period of 6 
months. 65 cases were symptom free at the end of the study. 
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SUMMARY 
This is a study involving 100 cases out of which70 cases proved to be 
tuberculous cervical lymphadenitis. These cases were studied at Govt. Kilpauk 
Medical College and Hospital for a period of 1 year from Aug2013-Aug2014. 
1. Tuberculosis is more common in the 21-30 years age group which is 
about 35 cases (50%) according to the present study. The youngest in the 
present series is 12 years of age. 
2. The disease showed a preponderance in females as compared to the male 
patients with the female to male ratio being 1.5:1. It is quite similar to 
that of the Salman M et al study where the female to male ratio is 1.4:1.  
3. It is more common in the lower socio-economic status people (90%). 
4. The disease shows increased incidence among the rural population which 
accounts for about 70% . 
5. All the 70 cases presented with the complaint of swelling in the neck. 
14cases presented with fever, 7cases presented with pain, weight loss and 
cough respectively.  The left side nodes are most commonly involved 
(57.1%). The lymph node involvement was discrete in 77.1%  and firm in 
70% . 22.9%  presented with matted lymph nodes according to the 
present study. The upper deep cervical nodes were involved in 60%  
which was the most common lymph node involved in tuberculous 
cervical lymphadenopathy. 
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6. 57.1%  presented with raised ESR according to the present study. 8.6%  
had features suggestive of pulmonary tuberculosis on chest x-ray. 82.9%  
showed caseating granuloma on FNAC.  
7. FNAC was inconclusive in 17.1%  which were then subsequently 
subjected to Excision Biopsy which proved positive for tuberculous 
cervical lymphadenopathy.  
8. Tuberculin test was positive in 27.1% . 
9. The patients were then categorised as Category I or Category II patients 
and were put on Anti-tubercular treatment based on the histopathological 
(FNAC/Excision Biopsy) reports. For the first 2 months , patients under 
category I were given INH, Rifampicin, Ethambutol and pyrazinamide 
and under category III were given INH, pyrazinamide, rifampicin. In the 
continuation phase only INH and rifampicin were given to the patients for 
a period of 4 months. They were followed up for a period of 6 months. 65 
cases were symptom free at the end of the study. 
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ANNEXURE-I 
     PROFORMA 
1) PARTICULARS OF THE PATIENT: 
 
Name:     
Age: 
Sex: 
I.P/O.P no: 
Religion: 
Occupation: 
Income: 
 
2)  CHIEF COMPLAINS: 
3) HISTORY OF PRESENT ILLNES: 
a) Duration of node enlargement/ swelling in the neck 
b) Associated symptoms 
 Fever and cough 
 Loss of appetite 
 Throat pain 
 Oropharyngeal and scalp sepsis. 
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c) Pain 
d) Sinus present or absent 
If so, 1) duration 
   ii) How did it start 
  iii) Nature of discharge 
4) PAST HISTORY 
 Pulmonary or Extrapulmonary  
 Lymphadenitis 
5) FAMILY HISTORY 
6) PERSONAL HISTORY 
 Contact with tuberculosis 
 Habit of taking unboiled milk 
 Living conditions and diet 
7) MENSTRUAL /  OBSTETRIC HISTORY 
8) GENERAL PHYSICAL EXAMINATION 
 Build  
 Febrile  
 Anemia 
 Jaundice 
 Clubbing 
 Lymphadenopathy 
 Weight  
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 Pulse  
 Blood pressure 
SYSTEMIC EXAMINATION 
 CVS 
 Respiratory system 
 Abdomen 
o Liver 
o Spleen 
o Lymph nodes 
o Others 
 Local examination: swelling in the neck 
o Unilateral- single groups or multiple groups 
o Bilateral- single groups or multiple groups 
o Skin over the swelling  
 Associated with any other group of lymph nodes 
 Axillary  -pectoral 
                 Subscapular 
                 Lateral 
          Central 
           Apical 
 Inguinal- horizontal 
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         Vertical 
  Mediastinal  
 Nature of the nodes 
 Situation 
 Size  
 Shape 
 Number 
 Inflammation 
 Consistency 
 Discrete or matted 
 Fixity ] 
 Skin involvement 
 Surface 
 Sinus if present 
 Number 
 Situation 
 Search for feeding node 
 Discharge 
 Other physical character 
 Examination of draining area 
 Oral cavity 
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 Tonsil 
9) INVESTIGATIONS 
a. Blood 
Hb% 
TC 
DC 
ESR 
b. Sputum if present for AFB 
c. Radiological examination 
X-ray neck 
X-ray chest 
d. Biopsy 
Macroscopic picture 
Biopsy report 
e. Tuberculin test 
 
10) TREATMENT 
i. Anti tubercular  
ii. Supportive 
iii. Surgical 
 
11) FOLLOW UP
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ANNEXURE-II 
MASTER CHART 
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KEY TO MASTER CHART 
M                          : Male 
F                            : Female 
IP                          : Inpatient 
OP                        : Out patient 
SES                       : Socioeconomic status 
RUR                     : Rural 
URB                     : Urban 
DIS                       : Discrete 
RT                        : Right 
LT                        : Left 
UDC                    : Upper deep cervical node 
LDC                     : Lower deep cervical node 
PT                       : Posterior triangle node 
SM                     : Submandibular node 
MUL                  : Multiple group  
BL                      : Bilateral 
L                        : Lower  
M                      : Middle 
H                       : Higher 
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